NNVC Jul 2024 7.500 call
| Previous Close | 0.2500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.7500 |
| Strike | 7.50 |
| Expire Date | 2024-07-19 |
| Day's Range | 0.2500 - 0.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
ACCESSWIREA Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum antiviral NV-387 could be an important ...
- ACCESSWIRE
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.:NNVC) (the "Company"), a clinical stage company and global leader in broad-spectrum antiviral nanomedicines, reports that the ultra-broad-spectrum antiviral NV-387, a clinical ...
ACCESSWIREOrally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON, CT / ACCESSWIRE / June 11, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a ...
